 Shaikh Atif
Concepts (286)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD4-Positive T-Lymphocytes | 13 | 2026 | 1129 | 2.840 |
Why?
| | Berylliosis | 7 | 2026 | 202 | 2.750 |
Why?
| | Dendritic Cells | 9 | 2026 | 499 | 1.710 |
Why?
| | Sarcoidosis | 4 | 2024 | 160 | 1.640 |
Why?
| | Flagellin | 6 | 2020 | 19 | 1.260 |
Why?
| | Chemokine CCL3 | 2 | 2026 | 26 | 1.130 |
Why?
| | Lung Injury | 2 | 2022 | 237 | 1.060 |
Why?
| | B-Lymphocytes | 3 | 2025 | 876 | 1.060 |
Why?
| | Lung | 10 | 2026 | 4109 | 1.010 |
Why?
| | Adaptive Immunity | 7 | 2022 | 169 | 0.990 |
Why?
| | Receptors, Interleukin-1 Type I | 1 | 2025 | 25 | 0.880 |
Why?
| | Monocytes | 5 | 2021 | 538 | 0.830 |
Why?
| | Renin-Angiotensin System | 1 | 2024 | 78 | 0.820 |
Why?
| | Macrophages, Alveolar | 5 | 2020 | 368 | 0.810 |
Why?
| | Mice, Knockout | 12 | 2026 | 3121 | 0.750 |
Why?
| | Beryllium | 5 | 2025 | 161 | 0.700 |
Why?
| | HLA-DP beta-Chains | 3 | 2021 | 87 | 0.650 |
Why?
| | Salmonella Infections | 3 | 2020 | 60 | 0.640 |
Why?
| | Mice | 28 | 2026 | 18339 | 0.630 |
Why?
| | Signal Transduction | 6 | 2025 | 5226 | 0.620 |
Why?
| | Salmonella typhimurium | 4 | 2020 | 190 | 0.620 |
Why?
| | Antigens, Bacterial | 2 | 2026 | 125 | 0.620 |
Why?
| | Melanoma, Experimental | 1 | 2018 | 108 | 0.540 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2025 | 459 | 0.530 |
Why?
| | CD11b Antigen | 2 | 2018 | 60 | 0.520 |
Why?
| | Mice, Transgenic | 10 | 2026 | 2182 | 0.520 |
Why?
| | Immunoglobulin M | 1 | 2018 | 284 | 0.520 |
Why?
| | Mice, Inbred C57BL | 17 | 2025 | 5992 | 0.510 |
Why?
| | Animals | 34 | 2026 | 38058 | 0.500 |
Why?
| | Antigens, Neoplasm | 1 | 2018 | 271 | 0.500 |
Why?
| | Membrane Lipids | 2 | 2008 | 83 | 0.500 |
Why?
| | Spermatozoa | 2 | 2008 | 109 | 0.490 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2016 | 42 | 0.480 |
Why?
| | Liposomes | 2 | 2008 | 250 | 0.450 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2018 | 917 | 0.450 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2015 | 47 | 0.440 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 375 | 0.440 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2014 | 22 | 0.440 |
Why?
| | Skin Transplantation | 1 | 2015 | 85 | 0.430 |
Why?
| | Disease Models, Animal | 7 | 2026 | 4557 | 0.430 |
Why?
| | Salmonella typhi | 1 | 2014 | 12 | 0.420 |
Why?
| | Macrophages | 7 | 2026 | 1511 | 0.420 |
Why?
| | Chemokine CCL4 | 2 | 2026 | 31 | 0.410 |
Why?
| | Lymph Nodes | 4 | 2020 | 502 | 0.400 |
Why?
| | Biomarkers | 2 | 2024 | 4271 | 0.400 |
Why?
| | Integrin alpha Chains | 1 | 2013 | 22 | 0.390 |
Why?
| | Repressor Proteins | 2 | 2016 | 437 | 0.370 |
Why?
| | Toll-Like Receptor 5 | 4 | 2014 | 18 | 0.370 |
Why?
| | Granuloma | 3 | 2022 | 96 | 0.350 |
Why?
| | Graft Rejection | 1 | 2015 | 540 | 0.350 |
Why?
| | Inflammation | 6 | 2025 | 2878 | 0.350 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2014 | 433 | 0.350 |
Why?
| | Antigens | 3 | 2021 | 347 | 0.340 |
Why?
| | Immunity, Innate | 5 | 2025 | 846 | 0.330 |
Why?
| | Colitis | 2 | 2025 | 280 | 0.330 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 905 | 0.310 |
Why?
| | Antigens, CD | 1 | 2013 | 555 | 0.310 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2021 | 131 | 0.300 |
Why?
| | Phagocytes | 3 | 2020 | 81 | 0.300 |
Why?
| | Bacterial Proteins | 3 | 2026 | 955 | 0.280 |
Why?
| | Heme Oxygenase-1 | 2 | 2025 | 74 | 0.270 |
Why?
| | Myeloid Differentiation Factor 88 | 3 | 2019 | 114 | 0.260 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 245 | 0.250 |
Why?
| | Chronic Disease | 5 | 2025 | 1813 | 0.250 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2021 | 175 | 0.250 |
Why?
| | Sperm-Ovum Interactions | 1 | 2006 | 12 | 0.240 |
Why?
| | BCG Vaccine | 1 | 2026 | 27 | 0.240 |
Why?
| | Membrane Fusion | 1 | 2006 | 40 | 0.240 |
Why?
| | Membrane Proteins | 4 | 2025 | 1166 | 0.230 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2637 | 0.220 |
Why?
| | Receptors, CXCR5 | 1 | 2025 | 27 | 0.220 |
Why?
| | Oocytes | 1 | 2006 | 178 | 0.220 |
Why?
| | Plastics | 1 | 2025 | 47 | 0.220 |
Why?
| | Exosomes | 1 | 2026 | 104 | 0.220 |
Why?
| | Spleen | 3 | 2016 | 508 | 0.200 |
Why?
| | Carcinogenesis | 1 | 2025 | 229 | 0.200 |
Why?
| | Immunologic Memory | 1 | 2026 | 366 | 0.200 |
Why?
| | Lymphocyte Activation | 3 | 2018 | 1126 | 0.200 |
Why?
| | Colonic Neoplasms | 1 | 2025 | 259 | 0.200 |
Why?
| | Iron | 1 | 2025 | 359 | 0.190 |
Why?
| | Cytokines | 5 | 2020 | 2061 | 0.190 |
Why?
| | Trophoblasts | 1 | 2025 | 216 | 0.190 |
Why?
| | Tuberculosis | 1 | 2026 | 291 | 0.190 |
Why?
| | Mycobacterium tuberculosis | 1 | 2026 | 334 | 0.180 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 169 | 0.180 |
Why?
| | Fetal Development | 1 | 2025 | 299 | 0.180 |
Why?
| | Aspergillus nidulans | 1 | 2021 | 6 | 0.180 |
Why?
| | Inflammasomes | 3 | 2023 | 146 | 0.170 |
Why?
| | Antigen Presentation | 3 | 2014 | 205 | 0.170 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 210 | 0.170 |
Why?
| | Intestinal Mucosa | 2 | 2025 | 676 | 0.170 |
Why?
| | Group VI Phospholipases A2 | 1 | 2020 | 6 | 0.170 |
Why?
| | Cells, Cultured | 4 | 2020 | 4154 | 0.160 |
Why?
| | Peptides | 1 | 2026 | 995 | 0.160 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2020 | 186 | 0.150 |
Why?
| | Mice, Inbred BALB C | 3 | 2026 | 1253 | 0.150 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2023 | 291 | 0.150 |
Why?
| | Interferon Type I | 1 | 2020 | 145 | 0.150 |
Why?
| | Tertiary Lymphoid Structures | 1 | 2019 | 7 | 0.150 |
Why?
| | Chemokine CXCL13 | 1 | 2019 | 15 | 0.150 |
Why?
| | Calcium-Binding Proteins | 1 | 2020 | 219 | 0.150 |
Why?
| | Gene Expression Regulation | 3 | 2020 | 2608 | 0.150 |
Why?
| | Tumor Microenvironment | 1 | 2023 | 732 | 0.140 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2020 | 95 | 0.140 |
Why?
| | Nanoparticles | 1 | 2025 | 519 | 0.140 |
Why?
| | CD40 Ligand | 1 | 2018 | 40 | 0.140 |
Why?
| | Genome, Viral | 1 | 2020 | 218 | 0.140 |
Why?
| | Antigen-Presenting Cells | 1 | 2018 | 160 | 0.140 |
Why?
| | Chemokines | 1 | 2019 | 218 | 0.140 |
Why?
| | Humans | 19 | 2026 | 144759 | 0.140 |
Why?
| | Thermolysin | 1 | 2018 | 4 | 0.140 |
Why?
| | Collagenases | 1 | 2018 | 22 | 0.140 |
Why?
| | Gene Expression Profiling | 3 | 2020 | 1782 | 0.140 |
Why?
| | Pancreatic Elastase | 1 | 2018 | 55 | 0.140 |
Why?
| | CD11c Antigen | 1 | 2018 | 40 | 0.130 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2018 | 38 | 0.130 |
Why?
| | Receptors, IgG | 1 | 2018 | 76 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 1 | 2020 | 415 | 0.130 |
Why?
| | Flow Cytometry | 3 | 2016 | 1173 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Bacterial Load | 2 | 2014 | 67 | 0.130 |
Why?
| | Lymphocytes | 1 | 2019 | 382 | 0.130 |
Why?
| | Anti-Inflammatory Agents | 1 | 2020 | 474 | 0.120 |
Why?
| | Ovalbumin | 3 | 2016 | 190 | 0.120 |
Why?
| | Mononuclear Phagocyte System | 1 | 2016 | 10 | 0.120 |
Why?
| | Cell Proliferation | 3 | 2014 | 2496 | 0.120 |
Why?
| | Antigens, Ly | 1 | 2016 | 40 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2020 | 1217 | 0.110 |
Why?
| | Histocompatibility Testing | 1 | 2015 | 121 | 0.110 |
Why?
| | Lung Diseases | 1 | 2022 | 787 | 0.110 |
Why?
| | Pancreatic Neoplasms | 1 | 2023 | 919 | 0.110 |
Why?
| | Receptors, Immunologic | 2 | 2015 | 206 | 0.110 |
Why?
| | Syk Kinase | 1 | 2014 | 22 | 0.110 |
Why?
| | Female | 13 | 2026 | 78271 | 0.110 |
Why?
| | Receptors, Interleukin-2 | 1 | 2014 | 64 | 0.110 |
Why?
| | Phagosomes | 1 | 2014 | 40 | 0.110 |
Why?
| | Adoptive Transfer | 1 | 2015 | 198 | 0.110 |
Why?
| | Protease Inhibitors | 2 | 2005 | 102 | 0.110 |
Why?
| | Germinal Center | 1 | 2014 | 67 | 0.100 |
Why?
| | Lysosomes | 1 | 2014 | 128 | 0.100 |
Why?
| | Transplantation, Homologous | 1 | 2015 | 415 | 0.100 |
Why?
| | Male | 11 | 2025 | 72315 | 0.100 |
Why?
| | Interleukin-2 | 1 | 2014 | 437 | 0.100 |
Why?
| | Immunoglobulin G | 3 | 2021 | 893 | 0.100 |
Why?
| | Heme | 2 | 2025 | 89 | 0.100 |
Why?
| | Th1 Cells | 1 | 2014 | 139 | 0.100 |
Why?
| | Mesentery | 1 | 2013 | 45 | 0.100 |
Why?
| | Toll-Like Receptors | 1 | 2014 | 194 | 0.090 |
Why?
| | Cell Communication | 1 | 2014 | 324 | 0.090 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2014 | 327 | 0.090 |
Why?
| | Gene Expression | 2 | 2014 | 1490 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1982 | 0.090 |
Why?
| | Salmonella Infections, Animal | 1 | 2011 | 39 | 0.080 |
Why?
| | Endocytosis | 1 | 2010 | 168 | 0.080 |
Why?
| | Muramidase | 1 | 2010 | 67 | 0.080 |
Why?
| | Up-Regulation | 1 | 2012 | 851 | 0.070 |
Why?
| | Hypersensitivity, Delayed | 1 | 2008 | 29 | 0.070 |
Why?
| | CD4 Lymphocyte Count | 1 | 2008 | 277 | 0.070 |
Why?
| | Drug Compounding | 1 | 2008 | 107 | 0.070 |
Why?
| | Cell Line | 2 | 2020 | 2882 | 0.070 |
Why?
| | Drug Carriers | 1 | 2008 | 130 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2008 | 1047 | 0.060 |
Why?
| | Immunophenotyping | 2 | 2020 | 322 | 0.060 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 442 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 851 | 0.060 |
Why?
| | Cell Lineage | 2 | 2020 | 376 | 0.060 |
Why?
| | Gene Targeting | 1 | 2006 | 82 | 0.060 |
Why?
| | Immunization, Secondary | 1 | 2026 | 91 | 0.060 |
Why?
| | Transcription Factors | 1 | 2014 | 1741 | 0.060 |
Why?
| | Amylases | 1 | 2005 | 18 | 0.060 |
Why?
| | Phaseolus | 1 | 2005 | 6 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 160 | 0.060 |
Why?
| | Polyethylene Terephthalates | 1 | 2025 | 21 | 0.060 |
Why?
| | Interferon-gamma | 1 | 2008 | 784 | 0.060 |
Why?
| | HIV Infections | 1 | 2020 | 3154 | 0.050 |
Why?
| | Helminths | 1 | 2004 | 11 | 0.050 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2006 | 178 | 0.050 |
Why?
| | Lipopolysaccharides | 2 | 2020 | 863 | 0.050 |
Why?
| | Insecta | 1 | 2004 | 74 | 0.050 |
Why?
| | Phagocytosis | 2 | 2016 | 299 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2363 | 0.050 |
Why?
| | Cell Death | 1 | 2025 | 383 | 0.050 |
Why?
| | Colon | 1 | 2025 | 304 | 0.050 |
Why?
| | Toll-Like Receptor 4 | 2 | 2016 | 276 | 0.050 |
Why?
| | Plants | 1 | 2004 | 226 | 0.050 |
Why?
| | Drug Delivery Systems | 1 | 2006 | 380 | 0.050 |
Why?
| | Viruses | 1 | 2004 | 165 | 0.050 |
Why?
| | Deoxycytidine | 1 | 2023 | 221 | 0.050 |
Why?
| | Interleukins | 1 | 2023 | 248 | 0.040 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2023 | 381 | 0.040 |
Why?
| | Organoids | 1 | 2023 | 141 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 824 | 0.040 |
Why?
| | RNA | 2 | 2020 | 940 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2025 | 449 | 0.040 |
Why?
| | Antigens, Fungal | 1 | 2021 | 28 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2023 | 395 | 0.040 |
Why?
| | HLA-DR3 Antigen | 1 | 2021 | 76 | 0.040 |
Why?
| | Hybridomas | 1 | 2021 | 234 | 0.040 |
Why?
| | Immune Tolerance | 1 | 2023 | 379 | 0.040 |
Why?
| | Pyroptosis | 1 | 2020 | 5 | 0.040 |
Why?
| | Fungal Proteins | 1 | 2021 | 145 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 780 | 0.040 |
Why?
| | Antigens, CD1 | 1 | 2020 | 60 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2020 | 44 | 0.040 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 11 | 0.040 |
Why?
| | Naphthalenes | 1 | 2020 | 56 | 0.040 |
Why?
| | Ketones | 1 | 2020 | 53 | 0.040 |
Why?
| | Lysophospholipids | 1 | 2020 | 77 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2020 | 173 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2023 | 961 | 0.040 |
Why?
| | Smokers | 1 | 2020 | 137 | 0.040 |
Why?
| | Homeostasis | 1 | 2023 | 640 | 0.040 |
Why?
| | Species Specificity | 1 | 2020 | 574 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2025 | 1125 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2020 | 130 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 626 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2025 | 1339 | 0.040 |
Why?
| | Down-Regulation | 1 | 2020 | 627 | 0.030 |
Why?
| | Placenta | 1 | 2025 | 780 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2020 | 636 | 0.030 |
Why?
| | Cell Membrane | 1 | 2020 | 706 | 0.030 |
Why?
| | Organ Specificity | 1 | 2017 | 312 | 0.030 |
Why?
| | Tryptophan | 2 | 2010 | 181 | 0.030 |
Why?
| | Adult | 4 | 2021 | 40449 | 0.030 |
Why?
| | Thymocytes | 1 | 2016 | 34 | 0.030 |
Why?
| | Toll-Like Receptor 7 | 1 | 2016 | 43 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 320 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2023 | 3540 | 0.030 |
Why?
| | Transplantation Chimera | 1 | 2015 | 56 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.030 |
Why?
| | Genetic Variation | 1 | 2020 | 983 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.030 |
Why?
| | Cadaver | 1 | 2016 | 304 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2016 | 321 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2015 | 94 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2014 | 162 | 0.030 |
Why?
| | Clone Cells | 1 | 2014 | 266 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 294 | 0.030 |
Why?
| | Chlamydia | 1 | 2014 | 10 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3604 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2014 | 139 | 0.020 |
Why?
| | Salmonella | 1 | 2014 | 61 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 758 | 0.020 |
Why?
| | Smoking | 1 | 2020 | 1472 | 0.020 |
Why?
| | Ultraviolet Rays | 1 | 2016 | 388 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 341 | 0.020 |
Why?
| | Chlamydia muridarum | 1 | 2012 | 2 | 0.020 |
Why?
| | Mice, Congenic | 1 | 2012 | 23 | 0.020 |
Why?
| | Immunization | 1 | 2014 | 374 | 0.020 |
Why?
| | Pulmonary Alveoli | 1 | 2015 | 383 | 0.020 |
Why?
| | Interleukin-18 | 1 | 2014 | 235 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 86 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2015 | 509 | 0.020 |
Why?
| | Pregnancy | 1 | 2025 | 7190 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2014 | 371 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1694 | 0.020 |
Why?
| | Chlamydia Infections | 1 | 2012 | 81 | 0.020 |
Why?
| | Genes, MHC Class II | 1 | 2010 | 76 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2017 | 1496 | 0.020 |
Why?
| | Acrylamide | 1 | 2010 | 3 | 0.020 |
Why?
| | Salts | 1 | 2010 | 37 | 0.020 |
Why?
| | Potassium Chloride | 1 | 2010 | 40 | 0.020 |
Why?
| | Protein Denaturation | 1 | 2010 | 75 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2010 | 150 | 0.020 |
Why?
| | Chickens | 1 | 2010 | 191 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 331 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2010 | 168 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 1045 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3162 | 0.020 |
Why?
| | Middle Aged | 2 | 2021 | 35875 | 0.020 |
Why?
| | Protein Folding | 1 | 2010 | 279 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2010 | 561 | 0.020 |
Why?
| | Apoptosis | 1 | 2016 | 2430 | 0.020 |
Why?
| | Protein Conformation | 1 | 2010 | 946 | 0.020 |
Why?
| | Chromatography, DEAE-Cellulose | 1 | 2005 | 12 | 0.010 |
Why?
| | Cystine | 1 | 2005 | 18 | 0.010 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2005 | 85 | 0.010 |
Why?
| | Molecular Weight | 1 | 2005 | 327 | 0.010 |
Why?
| | Bacillus thuringiensis | 1 | 2004 | 6 | 0.010 |
Why?
| | Tyrosine | 1 | 2005 | 222 | 0.010 |
Why?
| | Genetic Engineering | 1 | 2004 | 93 | 0.010 |
Why?
| | Genetic Markers | 1 | 2004 | 331 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 7173 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 337 | 0.010 |
Why?
| | Kinetics | 1 | 2005 | 1627 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2005 | 2930 | 0.010 |
Why?
|
|
Atif's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|